Akina Tamaki

Dr. Akina Tamaki

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2021 in JAMA Otolaryngology–Head & Neck Surgery
Verified
Journal Article
Open access
PDF file
ATAkina Tamaki
Akina Tamaki
CCClaudia I. Cabrera
Claudia I. Cabrera
SLShawn Li
Shawn Li
CRCyrus Rabbani
Cyrus Rabbani
JTJason E. Thuener
Jason E. Thuener
NFNicole Fowler
Nicole Fowler
SARS-CoV-2, and its clinical manifestation as COVID-19, is an ongoing global pandemic. Patients with COVID-19 can present with numerous otolaryngologic conditions, such as Bell palsy (BP). Bell palsy is a unilateral peripheral facial nerve palsy of sudden onset. Several case reports and series have described peripheral facial nerve palsies associated with COVID-19.1 In addition, since the US Food and Drug Administration’s (FDA) emergency use authorization of several COVID-19 vaccines, there have been media reports of BP associated with vaccination.2 Such concerns could erode vaccine confidence and exacerbate public hesitancy to obtain a COVID-19 vaccine. We used data from a large health research network to estimate the incidence of BP in patients with COVID-19 vs individuals vaccinated against the disease.

1 February 2020 in Oral Oncology
Verified
Journal Article
Closed access
ATAkina Tamaki
Akina Tamaki
JRJames W. Rocco
James W. Rocco
EOEnver Ozer
Enver Ozer

27 October 2017 in Head & Neck
Verified
Journal Article
Closed access
PDF file
ATAkina Tamaki
Akina Tamaki
BMBrett A. Miles
Brett A. Miles
MLMiriam Lango
Miriam Lango
LKLuiz Kowalski
Luiz Kowalski
CZChad A. Zender
Chad A. Zender

18 October 2021 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
KPKavya Pai
Kavya Pai
CBCarla Baaklini Bs
Carla Baaklini Bs
CCClaudia I. Cabrera
Claudia I. Cabrera
ATAkina Tamaki
Akina Tamaki
NFNicole Fowler
Nicole Fowler
NMNicole Maronian
Nicole Maronian

13 April 2022 in Head & Neck
Verified
Journal Article
Open access
HQHumzah A. Quereshy
Humzah A. Quereshy
BQBrooke A. Quinton
Brooke A. Quinton
CCClaudia I. Cabrera
Claudia I. Cabrera
SLShawn Li
Shawn Li
ATAkina Tamaki
Akina Tamaki
NFNicole Fowler
Nicole Fowler
Background: Considering limited data exploring reimbursement trends at the subspecialty level within head and neck surgical oncology, we sought to characterize these trends for head and neck‐specific codes from 2000 to 2020.Methods: Using the Centers for Medicare and Medicaid Services' Physician Fee Schedule Look‐Up Tool, reimbursement data, adjusted to 2020 U.S. dollars, for 37 head and neck surgical oncologic procedure codes were collected from 2000 to 2020.Results: From 2000 to 2020, despite gross reimbursement for all head and neck procedures increasing by 23.2%, when adjusted for inflation, physician reimbursement decreased by 19.4%. Only 4 of 37 examined codes increased in net reimbursement over the study period.Conclusion: Medicare reimbursement for the most common head and neck oncologic procedure codes decreased from 2000 to 2020. Further research is necessary to explore the implications of these trends on the delivery of patient care.

10 May 2023 in Otolaryngologic Clinics of North America
Verified
Journal Article
Closed access
ATAkina Tamaki
Akina Tamaki
CZChad A. Zender
Chad A. Zender